Taiwan clears VUNO’s AI fundus evaluation device
South Korean agency VUNO has gained the approval of Taiwan’s Meals and Drug Administration to market its AI fundus evaluation software program.
VUNO Med-Fundus AI analyses pictures of the fundus to rapidly detect places of lesions indicative of retinal ailments, together with diabetic retinopathy, macular illness and glaucoma.
This newest certification follows Taiwan FDA’s clearance for its different AI merchandise, VUNO-Med Chest X-ray and VUNO-Med Bone Age. Simply two months in the past, VUNO obtained Singapore’s clearance for VUNO Med-Fundus AI.
Examine validates AIRS Medical’s AI resolution for denoising 3D MR pictures
AIRS Medical, a medical AI startup from South Korea, has lately proved in a examine the aptitude of its AI-powered MRI reconstruction resolution, SwiftMR, to denoise and tremendously enhance the standard of 3D MR pictures.
Based mostly on its findings, a deep neural network-based noise discount and picture high quality enchancment device outperformed the traditional magnetisation-prepared speedy gradient-echo (MP-RAGE) sequence in bettering MR picture high quality.
“We’re very happy that we’ve proved SwiftMR contributes to not solely decreasing time but additionally [helping] make pictures nice, ultimately [helping] radiologists learn pictures with confidence,” mentioned AIRS Medical CEO Dr Hyeseong Lee.
Qure.ai packages options utilizing NVIDIA’s MONAI package
Indian well being expertise startup Qure.ai is likely one of the early adopters of NVIDIA’s newest open-source framework for deploying AI medical imaging functions.
The MONAI Software Packages (MAP) simplify the method of deploying an AI mannequin in an present healthcare ecosystem.
Qure.ai is now packaging its AI options for deployment utilizing MAPs, accelerating its medical influence, in line with NVIDIA.
UK-based Cambridge Cognition brings mind well being options to China
London-listed Cambridge Cognition, a supplier of cognitive evaluation check options, has entered into a brand new partnership to deliver its digital well being choices to China.
The corporate lately signed a 10-year unique licensing deal and strategic partnership with Luca Healthcare, an area developer of digital well being evaluation instruments.
Luca might be making Cambridge Cognition’s CANTAB suite of digital mind well being assessments accessible in China by way of its LucaPlex platform.
“China has over 265 million folks aged 60 years and above, of which 40 million folks have delicate cognitive impairment and 15 million folks with a type of dementia. With neurodegenerative ailments, early prognosis is the important thing to managing illness development. We’ll leverage Cambridge Cognition’s analysis, scientific know-how, and digital expertise to make accessible superior cognitive evaluation instruments for the medical trials market and the healthcare market in China,” mentioned Luca CEO Echo Chen.
